Evidence map›Paper›PMID 40957986›Full record

ReviewPediatric nephrology (Berlin, Germany)2026

AI-powered insights in pediatric nephrology: current applications and future opportunities.

Arwa Nada, Yamen Ahmed, Jieji Hu, Darcy Weidemann, Gregory H Gorman, Eva Glenn Lecea, Ibrahim A Sandokji, Stephen Cha, Stella Shin, Salar Bani-Hani and 8 more

Abstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Prenatal body fluid analysis in the evaluation of CAKUT.Pediatric nephrology (Berlin, Germany) · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Arwa NadaDepartment of Pediatrics, Division of Pediatric Nephrology, Loma Linda University Children's Hospital (LLUCH), Loma Linda University (LLU), 11175 Campus St. A1120H, Loma Linda, CA, 92350, USA. anada@llu.edu.ORCID http://orcid.org/0000-0003-0387-0194
Yamen AhmedCase Western Reserve University, Cleveland, OH, USA.
Jieji HuCollege of Medicine, Northeast Ohio Medical University, Rootstown, OH, USA.
Darcy WeidemannDepartment of Pediatrics, Children's Mercy Kansas City, and University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Gregory H GormanOffice of the Surgeon General, U.S. Army, Falls Church, USA.
Eva Glenn LeceaDepartment of Pediatrics, Division of Pediatric Nephrology, UCSF Benioff Children's Hospital, San Francisco, CA, USA.
Ibrahim A SandokjiDepartment of Pediatrics, Taibah University College of Medicine, Medinah, Saudi Arabia.
Stephen ChaDepartment of Pediatrics, Division of Pediatric Nephrology, Penn State Health Children's Hospital, Penn State, Hershey, PA, USA.
Stella ShinDepartment of Pediatrics, Division of Nephrology, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
Salar Bani-HaniDepartment of Pediatrics, Division of Pediatric Nephrology, Loma Linda University Children's Hopistal, Loma Linda University, Loma Linda, CA, USA.
Sai Sudha MannemuddhuDepartment of Medicine, East Tennessee Children's Hospital, University of Tennessee, Knoxville, TN, USA.
Rebecca L RuebnerDepartment of Pediatrics, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, USA.
Aadil KakajiwalaDepartment Pediatrics, Division of Critical Care Medicine, Children's National Hospital, Washington, D.C, USA.
Rupesh RainaDepartment of Pediatrics, Division of Pediatric Nephrology, Akron Children's Hospital, Akron, OH, USA.
Roshan GeorgeDepartment of Pediatrics, Division of Nephrology, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
Rim ElchakiDepartment of Pediatrics, Division of Pediatric Nephrology, UCSF Benioff Children's Hospital, San Francisco, CA, USA.
Michael L MoritzDepartment of Pediatrics, Division of Nephrology, Akron Children's Hospital, Akron, OH, USA.
The American Society of Pediatric Nephrology Quality Improvement and Artificial Intelligence (ASPN QI/AI) Interest Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is rapidly emerging as a transformative force in pediatric nephrology, enabling improvements in diagnostic accuracy, therapeutic precision, and operational workflows. By integrating diverse datasets-including patient histories, genomics, imaging, and longitudinal clinical records-AI-driven tools can detect subtle kidney anomalies, predict acute kidney injury, and forecast disease progression. Deep learning models, for instance, have demonstrated the potential to enhance ultrasound interpretations, refine kidney biopsy assessments, and streamline pathology evaluations. Coupled with robust decision support systems, these innovations also optimize medication dosing and dialysis regimens, ultimately improving patient outcomes. AI-powered chatbots hold promise for improving patient engagement and adherence, while AI-assisted documentation solutions offer relief from administrative burdens, mitigating physician burnout. However, ethical and practical challenges remain. Healthcare professionals must receive adequate training to harness AI's capabilities, ensuring that such technologies bolster rather than erode the vital doctor-patient relationship. Safeguarding data privacy, minimizing algorithmic bias, and establishing standardized regulatory frameworks are critical for safe deployment. Beyond clinical care, AI can accelerate pediatric nephrology research by identifying biomarkers, enabling more precise patient recruitment, and uncovering novel therapeutic targets. As these tools evolve, interdisciplinary collaborations and ongoing oversight will be key to integrating AI responsibly. Harnessing AI's vast potential could revolutionize pediatric nephrology, championing a future of individualized, proactive, and empathetic care for children with kidney diseases. Through strategic collaboration and transparent development, these advanced technologies promise to minimize disparities, foster innovation, and sustain compassionate patient-centered care, shaping a new horizon in pediatric nephrology research and practice.

Indexed as

Artificial IntelligenceKidney DiseasesNephrologyPediatricsChildHumansArtificial intelligenceKidney injuryNephrologyPediatrics

Identifiers

PMID40957986
PMCPMC13009068

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.